Elena Gardella, MD, PhDAssociate Professor, University of Southern Denmark
Danish Epilepsy Center–Filadelfia Department of Clinical Neurophysiology Presenting "The SCN8A-LOF phenotype" |
Michael Hammer, PhD
Research Scientist and Professor, BIO5 Institute, Department of Neurology, University of Arizona
Presenting "Connecting the dots: making sense of the multifarious manifestations of SCN8A syndrome" |
Chunhui Hu, MDChild Neurologist, Department of Neurology, Children’s Hospital of Fudan University
Presenting "Phenotypic and genetic spectrum in Chinese children with SCN8A-related disorders" |
Chris Makinson, PhDAssistant Professor of Neurological Sciences, Columbia University Department of Neurology, Department of Neuroscience
Institute for Genomic Medicine Columbia Translational Neuroscience Initiative Columbia Stem Cell Initiative Presenting "Mechanisms to treatments: Using animal and human cellular models to study SCN8A" |
Raquel MirallesNeuroscience Ph.D Candidate, University of Virginia, Patel Lab
Presenting "Aberrant Parvalbumin-Positive Interneuron Activity in SCN8A Epileptic Encephalopathy" |
Madeleine Oudin, PhDTiampo Family Assistant Professor of Biomedical Engineering, Tufts University
Presenting "Targeting alternative splicing to treat SCN8A epilepsy" |
M. Scott Perry, MDHead of Neurosciences, Jane and John Justin Institute for Mind Health at Cook Children’s
Director, Genetic Epilepsy Clinic Presenting "First global consensus for the diagnosis and treatment of SCN8A-related disorders: a Delphi project" |
Steven Petrou, PhDCo-Founder & Chief Scientific Officer, Praxis Precision Medicines
Presenting "PRAX-562 Potential Next-Generation Treatment for DEEs" |
Ian C. Wenker, PhDResearch Assistant Professor, Department of Anesthesiology, University of Virginia
Presenting "The neural circuitry of seizure behaviors in mouse models of SCN8A epilepsy” |
Svetlana Shore, PhDDirector, Clinical Development, Neurocrine Biosciences
Presenting "Neurocrine Biosciences Research Updates" |
Wenxi Yu, PhDResearch Investigator, Department of Human Genetics, University of Michigan
Presenting "Down-regulation of SCN8A as treatment for developmental and epileptic encephalopathy" |
Past Annual Reports
Past PCDH19 Efforts Privacy Policy The Cute Syndrome Foundation PO Box 842 Ozark, MO 65721 |
The Cute Syndrome is registered as a tax-exempt organization under IRS section 501(c)(3).
Our tax identification number is: 46-2699066. © The Cute Syndrome Foundation, All rights reserved |